Novel diabetes drug candidate shows promising properties in human islets and mouse models
Medigen Vaccine Biologics and Dynavax Technologies
Novavax Signs Vaccine Manufacturing Deal; Analyst Bullish On Upcoming Readout
Wells Fargo: These 3 'Strong Buy' Stocks Are Must-Watch Names
Neutralizing antibodies isolated from COVID-19 patients may suppress virus
GSK Buys 10% Stake In Germany’s CureVac To Develop mRNA Vaccines
Moleculin Pops 33% On Anti-Viral Activity For Potential Covid-19 Treatment
Why vaccines are less effective in the elderly, and what it means for COVID-19
First data on Oxford/AstraZeneca, CanSino coronavirus vaccines ‘promising’
UK announces COVID-19 vaccine deals with BioNTech/Pfizer and Valneva
A new anti-platelet drug shows potential for treating blood vessel clots in heart attacks, strokes and, possibly, COVID-19
Merck, Novocure Team Up On Lung Cancer Treatment; Trial Set For 2H20
Merck & Co’s CEO has doubts over fast COVID-19 vaccine development
GSK-partnered Medicago starts trials of plant-based COVID-19 vaccine
VXRT Stock Price Jumps on COVID-19 Operation Warp Speed Announcement
Vaxart: No Midnight Bells Ringing Yet for This Cinderella Biotech Story
3 Healthcare Stocks Under $5 With Triple-Digit Upside Potential
Kancera’s Unique Approach to COVID-19
IMV Pops 134% In Pre-Market On “Rapid Progress” Of Covid-19 Vaccine Development
Biogen, Eisai Start New Phase 3 Trial For Pre-clinical Alzheimer's Disease
Medicago and Dynavax
Can Novavax Win FDA Approval for COVID-19 Vaccine Before Year End? Analyst Weighs In
New study supports remdesivir as COVID-19 treatment
Lung, immune function in kids could protect from severe COVID-19
3 “Strong Buy” Micro-Cap Stocks That Offer Attractive Returns
Pfizer, BioNTech Rise On ‘Positive’ Early Data Of Potential Coronavirus Vaccine
Dr Reddy’s Inks Deal With Fujifilm To Sell Potential Avigan Covid-19 Drug
CRISPR Therapeutics Prices Public Offering; Analysts Bullish On CTX130 Potential
Vaxart Oral COVID-19 Vaccine Joins Trump’s “Warp Speed,” Ramps Up Manufacturing Capacity
3 "Strong Buy" Coronavirus Stocks With Massive Upside Potential